title: Neuromuscular disturbance outlasts other symptoms of exercise-induced muscle damage.
abstract: This study examined the biochemical, immunological, functional, and neuromuscular responses associated with exercise-induced muscle damage in the quadriceps of untrained men. Muscle damage and soreness was elicited with maximal concentric/eccentric muscle actions at 0.53 rads s(-1). Significant (P<0.05) soreness was evident 1, 2, and 3 days following muscle insult, while plasma creatine kinase, a marker of muscle damage, was elevated 3 and 5 days post-insult. Plasma interleukin-Ibeta was significantly increased within 5 min, and remained elevated 1, 2, 5, and 7 days post-insult. Maximal isometric quadriceps function was impaired (P<0. 05) for 5 days following muscle challenge. Maximal isokinetic performance at 1.09 rads s(-1) was diminished (P<0.05) for 2 days post-insult; no significant decrements at 3.14 rads s(-1) were noted. Average electrical activation (iEMG) of the quadriceps was unaltered, but iEMG activity of the rectus femoris - where soreness was focused - was significantly increased. Neuromuscular efficiency (torque/iEMG) was compromised throughout the 10-day post-insult period investigated. While other symptoms of exercise-induced muscle damage dissipate within 7 days, neuromuscular perturbation persists for at least 10 days.
authors.affiliation: Department of Kinesiology, The College of William & Mary, Williamsburg, VA 23187-8795, USA. mrdesc@facstaff.wm.edu
authors.forename: M R
authors.initials: MR
authors.lastname: Deschenes
authors.forename: R E
authors.initials: RE
authors.lastname: Brewer
authors.forename: J A
authors.initials: JA
authors.lastname: Bush
authors.forename: R W
authors.initials: RW
authors.lastname: McCoy
authors.forename: J S
authors.initials: JS
authors.lastname: Volek
authors.forename: W J
authors.initials: WJ
authors.lastname: Kraemer
mesh_terms: D000328:Adult; D015415:Biomarkers; D003402:Creatine Kinase / Q000097:blood*; D004576:Electromyography; D005080:Exercise Test / Q000009:adverse effects*; D006801:Humans; D007527:Isoenzymes; D007537:Isometric Contraction; D007866:Leg; D008297:Male; D018482:Muscle, Skeletal / Q000293:injuries* / Q000294:innervation / Q000473:pathology; D009220:Myositis / Q000097:blood / Q000209:etiology* / Q000473:pathology; D010146:Pain / Q000097:blood / Q000209:etiology* / Q000473:pathology
chemical_list: D015415:Biomarkers; D007527:Isoenzymes; D003402:Creatine Kinase